The rise of bogus healthcare conferences

When a reporter and a researcher from Nature arrived at the 25th Global Nephrology, Urology and Kidney Failure Congress, held at a 4-star hotel in London, they were surprised to find it existed largely in name only. The nephrology conference was described as “shambolic”—and the journal said the number of these lackluster events may be on the rise.

After being unable to find a sign for the event, an organizer allegedly told the outlet that the conference was being held alongside others, offering a variety of incongruous lectures that included topics such as dentistry and antibiotics. Nephrology seemed like an afterthought.

Much like low-value and predatory journals, conferences such as these are on the rise and all they offer is “weak or no peer review for presentations, poor organization, and a focus on making the organizers money,” according to Nature

Reporters said posters for the event remained wrapped, and there was little evidence an event was taking place. Further, what was supposed to be an all-day affair ended abruptly shortly after noon.

Experts interviewed by Nature suspect these conferences are popping up more frequently, ranging from low-effort to outright fraudulent. However, they’re happy to charge registration fees from journalists, vendors and researchers lured into attending from across the globe.

Read the feature at the link below for more.

Chad Van Alstin Health Imaging Health Exec

Chad is an award-winning writer and editor with over 15 years of experience working in media. He has a decade-long professional background in healthcare, working as a writer and in public relations.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”